Revance Therapeutics, Inc. (RVNC)
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DaxibotulinumtoxinA in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
$621.96M
Mr. Mark J. Foley
495.00
Nashville, TN
Feb 06, 2014
-1.74
$-3.43
1.91
5.12
-194.53%
-1.67
0.06
22.59
3.41
4.55
-60.68%
-915.54%
Similar stocks (15)
Cerevel Therapeutics Holdings, Inc.
CERE
Nuvalent, Inc.
NUVL
Blueprint Medicines Corporation
BPMC
Madrigal Pharmaceuticals, Inc.
MDGL
Apellis Pharmaceuticals, Inc.
APLS
Arcellx, Inc.
ACLX
Akero Therapeutics, Inc.
AKRO
Day One Biopharmaceuticals, Inc.
DAWN
89bio, Inc.
ETNB
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Terns Pharmaceuticals, Inc.
TERN
DiaMedica Therapeutics Inc.
DMAC
Amylyx Pharmaceuticals, Inc.
AMLX
Ventyx Biosciences, Inc.
VTYX
ETF Exposure (35)
ProShares Merger ETF
MRGR
3.3676651480167368%
Invesco NASDAQ Future Gen 200 ETF
QQQS
1.207%
Inspire Small/Mid Cap Impact ESG ETF
ISMD
0.48975290374167013%
IQ Merger Arbitrage ETF
MNA
0.34%
iShares U.S. Pharmaceuticals ETF
IHE
0.26111%
iShares Micro-Cap ETF
IWC
0.18343%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.069%
iShares Biotechnology ETF
IBB
0.05997%
iShares Russell 2000 Growth ETF
IWO
0.05318%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.03%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
iShares Russell 2000 ETF
IWM
0.02691%
ProShares Ultra Nasdaq Biotechnology
BIB
0.019759600196035707%
Fidelity MSCI Health Care Index ETF
FHLC
0.01014756%
ProShares Ultra Russell2000
UWM
0.010133083483267628%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0070542711%
ProShares UltraPro Russell2000
URTY
0.004995190054508174%
ProShares Hedge Replication ETF
HDG
0.004245912205478885%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.003206%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00119%
iShares Russell 3000 ETF
IWV
0.00103%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (15)
Cerevel Therapeutics Holdings, Inc.
CERE
Nuvalent, Inc.
NUVL
Blueprint Medicines Corporation
BPMC
Madrigal Pharmaceuticals, Inc.
MDGL
Apellis Pharmaceuticals, Inc.
APLS
Arcellx, Inc.
ACLX
Akero Therapeutics, Inc.
AKRO
Day One Biopharmaceuticals, Inc.
DAWN
89bio, Inc.
ETNB
Stoke Therapeutics, Inc.
STOK
Pliant Therapeutics, Inc.
PLRX
Terns Pharmaceuticals, Inc.
TERN
DiaMedica Therapeutics Inc.
DMAC
Amylyx Pharmaceuticals, Inc.
AMLX
Ventyx Biosciences, Inc.
VTYX
ETF Exposure (35)
ProShares Merger ETF
MRGR
3.3676651480167368%
Invesco NASDAQ Future Gen 200 ETF
QQQS
1.207%
Inspire Small/Mid Cap Impact ESG ETF
ISMD
0.48975290374167013%
IQ Merger Arbitrage ETF
MNA
0.34%
iShares U.S. Pharmaceuticals ETF
IHE
0.26111%
iShares Micro-Cap ETF
IWC
0.18343%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.069%
iShares Biotechnology ETF
IBB
0.05997%
iShares Russell 2000 Growth ETF
IWO
0.05318%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.03%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
iShares Russell 2000 ETF
IWM
0.02691%
ProShares Ultra Nasdaq Biotechnology
BIB
0.019759600196035707%
Fidelity MSCI Health Care Index ETF
FHLC
0.01014756%
ProShares Ultra Russell2000
UWM
0.010133083483267628%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0070542711%
ProShares UltraPro Russell2000
URTY
0.004995190054508174%
ProShares Hedge Replication ETF
HDG
0.004245912205478885%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.003206%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00119%
iShares Russell 3000 ETF
IWV
0.00103%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%